Ryan worked as an independent consultant in the field of oligonucleotide CMC prior to joining Tallac. Prior to consulting, he was the Head of Research Chemistry at Vitrisa Therapeutics responsible for synthesis of compounds to support discovery, biology, and DMPK. In addition to synthesis, the research chemistry group was responsible for analysis of internal compounds, oligo conjugation, and worked closely with the CMC group at Vitrisa to provide research support. Ryan has over 20 years’ experience in the pharma industry, spanning both large pharma to biotech startups and GMP to research. Prior to joining Vitrisa, Ryan led the analytical development and validation group at Novan Therapeutics, was an integral part of the team that moved the main candidate from Ph2 to Ph3 at Regado Biosciences, and top Quality Control trainer while leading QC validation efforts at Biogen Idec. Ryan received his B.Sc. Chemical Engineering, Polymer Science Concentration, from North Carolina State University.